Eagle Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Eagle Pharmaceuticals patents 16 in total
| Status | Patent |
|---|---|
Application | Utility: FORMULATIONS OF BENDAMUSTINE Filling date: 6 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: METHODS OF USING DANTROLENE TO TREAT NERVE AGENT EXPOSURE Filling date: 6 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: FULVESTRANT FORMULATIONS Filling date: 6 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: FORMULATIONS OF BENDAMUSTINE Filling date: 6 Sep 2025 Issue date: 23 Dec 2021 |
Grant | Utility: Fulvestrant formulations Filling date: 6 Sep 2025 Issue date: 23 Nov 2021 |
Application | Utility: FULVESTRANT FORMULATIONS AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 11 Nov 2021 |
Grant | Utility: Formulations of bendamustine Filling date: 6 Sep 2025 Issue date: 31 Aug 2021 |
Application | Utility: FULVESTRANT FORMULATIONS Filling date: 6 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: DANTROLENE FORMULATIONS AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: FORMULATIONS OF BENDAMUSTINE Filling date: 6 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: METHODS OF USING DANTROLENE TO TREAT NERVE AGENT EXPOSURE Filling date: 6 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: FORMULATIONS OF BENDAMUSTINE Filling date: 6 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: FULVESTRANT FORMULATIONS AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: FORMULATIONS OF BENDAMUSTINE Filling date: 6 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: FULVESTRANT FORMULATIONS Filling date: 6 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: FORMULATIONS OF BENDAMUSTINE Filling date: 6 Sep 2025 Issue date: 21 Nov 2019 |
Showing 1 to 16 of 16 patents.